MUREX RUB-EX
Device Facts
| Record ID | K954920 |
|---|---|
| Device Name | MUREX RUB-EX |
| Applicant | Murex Diagnostics, Inc. |
| Product Code | LQN · Microbiology |
| Decision Date | Aug 21, 1996 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 866.3510 |
| Device Class | Class 2 |
Indications for Use
The Murex Rūb-ex test is a rapid latex agglutination test for the qualitative and semi-quantitative determination of rubella antibodies in serum.
Device Story
Rapid latex agglutination test; detects rubella antibodies in serum samples. Inactivated/disrupted rubella virus sensitizes latex particles. Performed in clinical laboratory settings by trained personnel. Qualitative/semi-quantitative results obtained via visual observation of agglutination. Assists clinicians in assessing rubella immune status. Reagents contain 0.1% sodium azide preservative.
Clinical Evidence
Comparative studies performed against Becton Dickinson and Orion Diagnostics test kits. No specific sensitivity, specificity, or sample size metrics provided.
Technological Characteristics
Latex agglutination assay; utilizes inactivated/disrupted rubella virus; 0.1% sodium azide preservative; manual test kit format.
Indications for Use
Indicated for qualitative and semi-quantitative detection of rubella antibodies in human serum. No specific age or gender restrictions stated.
Regulatory Classification
Identification
Rubella virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to rubella virus in serum. The identification aids in the diagnosis of rubella (German measles) or confirmation of a person's immune status from past infections or immunizations and provides epidemiological information on German measles. Newborns infected in the uterus with rubella virus may be born with multiple congenital defects (rubella syndrome).
Special Controls
*Classification.* Class II. The special controls for this device are:(1) National Committee for Clinical Laboratory Standards': (i) 1/LA6 “Detection and Quantitation of Rubella IgG Antibody: Evaluation and Performance Criteria for Multiple Component Test Products, Speciment Handling, and Use of the Test Products in the Clinical Laboratory, October 1997,” (ii) 1/LA18 “Specifications for Immunological Testing for Infectious Diseases, December 1994,” (iii) D13 “Agglutination Characteristics, Methodology, Limitations, and Clinical Validation, October 1993,” (iv) EP5 “Evaluation of Precision Performance of Clinical Chemistry Devices, February 1999,” and (v) EP10 “Preliminary Evaluation of the Linearity of Quantitive Clinical Laboratory Methods, May 1998,” (2) Centers for Disease Control's: (i) Low Titer Rubella Standard, (ii) Reference Panel of Well Characterized Rubella Sera, and (3) World Health Organization's International Rubella Standard.
Predicate Devices
- Rubascan (Becton Dickinson)
- Rubalex (Orion Diagnostics)
Related Devices
- K952721 — RUBASCAN CARD TEST · Bd Becton Dickinson Vacutainer Systems Preanalytic · Dec 20, 1996
- K954687 — ACCESS RUBELLA IGG · Bio-Rad Laboratories, Inc. · Apr 9, 1996
- K971304 — QUANTA LITE REBELLA IGG · Inova Diagnostics, Inc. · Jan 2, 1998
- K031490 — RUBELLACOL · Immunostics Inc., · Jul 16, 2003